Bio-Path Hldgs Stock (NASDAQ: BPTH) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 331.000 / 1.391M |
Day Range | - - - |
52 Wk Range | 2.705 - 44.800 |
Market Cap | $4.461M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 4.31% |
Days to Cover | 1.92 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bio-Path Hldgs (NASDAQ: BPTH) through any online brokerage.
Other companies in Bio-Path Hldgs’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Geovax Labs (NASDAQ:GOVX) and NexImmune (NASDAQ:NEXI).
The latest price target for Bio-Path Hldgs (NASDAQ: BPTH) was reported by Roth MKM on Thursday, April 18, 2024. The analyst firm set a price target for 40.00 expecting BPTH to rise to within 12 months (a possible 1303.51% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Bio-Path Hldgs (NASDAQ: BPTH) is $2.85 last updated April 22, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Bio-Path Hldgs.
Bio-Path Hldgs’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Bio-Path Hldgs.
Bio-Path Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.